HomeATXS • NASDAQ
add
Astria Therapeutics Inc
Previous close
$7.84
Day range
$7.42 - $7.94
Year range
$3.56 - $12.92
Market cap
419.31M USD
Avg Volume
301.62K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 35.82M | 24.36% |
Net income | -33.05M | -36.74% |
Net profit margin | — | — |
Earnings per share | -0.57 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 259.18M | -26.93% |
Total assets | 281.92M | -23.39% |
Total liabilities | 21.41M | 2.39% |
Total equity | 260.51M | — |
Shares outstanding | 56.43M | — |
Price to book | 2.68 | — |
Return on assets | -30.24% | — |
Return on capital | -32.00% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -33.05M | -36.74% |
Cash from operations | -36.06M | -114.75% |
Cash from investing | 57.99M | 185.15% |
Cash from financing | — | — |
Net change in cash | 21.93M | 125.87% |
Free cash flow | -19.52M | -111.96% |
About
Founded
2008
Headquarters
Website
Employees
78
